IGHE and Allergy: We foresee that human monoclonal IgE as they become more readily available will continue to prove their extensive value in defining allergy-causing immune responses and in providing new solutions (e.g. new hypoallergenic variants as described in the past 18) that may be used to treat allergic disease in the clinic.